We are live on ! Find out more
MESO

Mesoblast
MESO

72 hedge funds and large institutions have $37.9M invested in Mesoblast in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

30% more call options, than puts

Call options by funds: $7.27M | Put options by funds: $5.59M

6% more funds holding

Funds holding: 68 → 72 (+4)

2.4% more ownership

Funds ownership: 0.31% → 2.72% (+2.4%)

10% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 21

23% less capital invested

Capital invested by funds: $49.2M → $37.9M (-$11.3M)

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
19
Reduced
21
Closed
11
Calls
$7.27M
Puts
$5.59M
Net Calls
+$1.69M
Net Calls Change
+$1.16M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$1.77M
2
PM
Penbrook Management
New York
+$982K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$848K
4
UBS Group
UBS Group
Switzerland
+$599K
5
Two Sigma Investments
Two Sigma Investments
New York
+$372K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$4.62M
2
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$1.87M
3
Group One Trading
Group One Trading
Illinois
-$676K
4
CSS
Cubist Systematic Strategies
Connecticut
-$669K
5
BlackRock
BlackRock
New York
-$651K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$7.15M -$651K -58,094 -8%
Morgan Stanley
2
Morgan Stanley
New York
$5.49M -$450K -40,166 -7%
Goldman Sachs
3
Goldman Sachs
New York
$4.52M +$1.77M +158,322 +62%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$2.55M -$295K -26,354 -10%
SXL
5
Summit X LLC
Missouri
$2.17M +$12.7K +1,132 +0.6%
UBS Group
6
UBS Group
Switzerland
$2.11M +$599K +53,492 +38%
PM
7
Penbrook Management
New York
$2.05M +$982K +87,675 +100%
MG
8
Marex Group
$1.09M – – –
Group One Trading
9
Group One Trading
Illinois
$990K -$676K -60,329 -40%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$933K +$848K +75,674 +757%
Citadel Advisors
11
Citadel Advisors
Florida
$813K -$4.62M -412,157 -85%
PWM
12
Prosperity Wealth Management
California
$546K +$15.7K +1,400 +3%
LPL Financial
13
LPL Financial
California
$545K +$112K +10,040 +25%
RIM
14
Rockbridge Investment Management
New York
$535K – – –
LCM
15
Lazari Capital Management
California
$506K +$11.2K +1,003 +2%
Marshall Wace
16
Marshall Wace
United Kingdom
$443K -$347K -30,941 -43%
FFA
17
Fi3 Financial Advisors
Indiana
$399K – – –
Two Sigma Investments
18
Two Sigma Investments
New York
$362K +$372K +33,213 New
Millennium Management
19
Millennium Management
New York
$352K +$170K +15,161 +89%
OMC
20
Oasis Management Company
Cayman Islands
$322K -$134K -11,926 -29%
Verition Fund Management
21
Verition Fund Management
Connecticut
$314K +$323K +28,844 New
Citigroup
22
Citigroup
New York
$282K +$4.13K +369 +1%
Wells Fargo
23
Wells Fargo
California
$276K -$14.6K -1,307 -5%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$200K +$840 +75 +0.4%
4WM
25
49 Wealth Management
Texas
$194K +$200K +17,829 New
1
2 3 4

MESO Hedge Fund Activity: Q2 2025 in Review

72 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2025, worth a combined $37.9M — down 23% from $49.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new MESO positions and 11 closed out — a net gain of 5 holders — while 19 added to existing stakes and 21 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $1.77M. The largest seller was Citadel Advisors, cutting an estimated $4.62M.

  • 72 institutional investors held Mesoblast (MESO) as of Q2 2025, up from 68 in Q1 2025.
  • Funds reported $37.9M of Mesoblast stock for Q2 2025, down 23% quarter-over-quarter.
  • 16 funds opened new Mesoblast positions in Q2 2025 and 11 closed out, a net change of +5 holders.
  • The largest Mesoblast buyer in Q2 2025 was Goldman Sachs, an estimated $1.77M added.
  • The largest Mesoblast seller in Q2 2025 was Citadel Advisors, an estimated $4.62M sold.

Based on aggregated 13F filings for Q2 2025.